These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12709000)

  • 1. Acral lentiginous melanoma: an immunohistochemical study of 20 cases.
    Kim YC; Lee MG; Choe SW; Lee MC; Chung HG; Cho SH
    Int J Dermatol; 2003 Feb; 42(2):123-9. PubMed ID: 12709000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acral lentiginous melanoma in situ: a study of nine cases.
    Kwon IH; Lee JH; Cho KH
    Am J Dermatopathol; 2004 Aug; 26(4):285-9. PubMed ID: 15249858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous PEComa: distinctive clear cell lesions of skin.
    Liegl B; Hornick JL; Fletcher CD
    Am J Surg Pathol; 2008 Apr; 32(4):608-14. PubMed ID: 18277881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens.
    Dorvault CC; Weilbaecher KN; Yee H; Fisher DE; Chiriboga LA; Xu Y; Chhieng DC
    Cancer; 2001 Oct; 93(5):337-43. PubMed ID: 11668469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi.
    Kim JC; Choi JW; Kim YC
    Am J Dermatopathol; 2023 Nov; 45(11):748-752. PubMed ID: 37856738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of MART-1, tyrosinase, and SM5-1 in primary and metastatic melanoma.
    Reinke S; Königer P; Herberth G; Audring H; Wang H; Ma J; Guo Y; Sterry W; Trefzer U
    Am J Dermatopathol; 2005 Oct; 27(5):401-6. PubMed ID: 16148409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases.
    Gupta D; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2004 Jun; 28(6):771-80. PubMed ID: 15166669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi.
    Mirecka J; Korabiowska M; Schauer A
    Pol J Pathol; 1995; 46(3):167-72. PubMed ID: 7496736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.
    Blessing K; Sanders DS; Grant JJ
    Histopathology; 1998 Feb; 32(2):139-46. PubMed ID: 9543670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
    Gajjar NA; Cochran AJ; Binder SW
    Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of melanoma antigens in epithelioid gastrointestinal stromal tumors: a potential diagnostic pitfall.
    Guler ML; Daniels JA; Abraham SC; Montgomery EA
    Arch Pathol Lab Med; 2008 Aug; 132(8):1302-6. PubMed ID: 18684030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.